Braskem SA has a consensus price target of $8.89 based on the ratings of 5 analysts. The high is $16.75 issued by Scotiabank on May 8, 2023. The low is $3.8 issued by UBS on September 26, 2025. The 3 most-recent analyst ratings were released by UBS, JP Morgan, and UBS on September 26, 2025, August 27, 2025, and September 18, 2024, respectively. With an average price target of $6.27 between UBS, JP Morgan, and UBS, there's an implied 74.07% upside for Braskem SA from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Braskem (NYSE:BAK) was reported by UBS on September 26, 2025. The analyst firm set a price target for $3.80 expecting BAK to rise to within 12 months (a possible 5.56% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Braskem (NYSE:BAK) was provided by UBS, and Braskem downgraded their neutral rating.
The last upgrade for Braskem SA happened on September 18, 2024 when UBS raised their price target to $10. UBS previously had a neutral for Braskem SA.
The last downgrade for Braskem SA happened on September 26, 2025 when UBS changed their price target from $5.1 to $3.8 for Braskem SA.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Braskem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Braskem was filed on September 26, 2025 so you should expect the next rating to be made available sometime around September 26, 2026.
While ratings are subjective and will change, the latest Braskem (BAK) rating was a downgraded with a price target of $5.10 to $3.80. The current price Braskem (BAK) is trading at is $3.60, which is out of the analyst’s predicted range.